Posts Tagged ‘ESV’

Bears Plunder Nokia Call Options

Today’s tickers: NOK, DG, ESV & OREX

NOK - Nokia Corp. – When Nokia yesterday announced that it was no longer meaningful to offer a forecast into its murky future, investors abandoned the stock driving it into new lower territory. We noticed frenzied options activity as investors reaped what premium they could from fast-falling call options. The dire nature of Nokia’s warning has left option traders with little doubt that its shares will flounder further in coming weeks. Bearish option traders wrote off at-the-money $7.00 call options expiring in just three weeks’ time for just 20 cents each. The question facing option bears seems to be not whether the shares will rebound but how far they will sink in the days ahead. On Wednesday the picture weakened with shares sliding by a further 7% to $6.50 while it appears that call options are once again being sold, but this time at lower strikes. Investors appeared to turn their attention to the $6.00 strike where volume of 3,000 built by mid-morning. Open interest of a mere 300 lots confirms that new positions are being taken. We saw at least 1,000 contracts clear the prevailing 59-cent bid on our screens. Sellers also decimated the premium available on July $7.00 strike calls with some 9,000 contract being traded Wednesday where premiums have halved to just 18-cents on the day. Investors seem convinced that Nokia’s fortunes look dire.

DG - Dollar General Corp. – The discount retailer missed Wall Street’s expectation for earnings when it reported its first quarter data of 48 cents. The Street was hoping for 50 cents. The seller of all-fine-things-for-less-than-$10 said it took losses on certain slow-to-clear items and said that shoppers were constrained by rising gas prices. It nevertheless stood by its full year estimate and continues to revise store…
continue reading


Tags: , , ,




Impending FDA Decision Spurs Options Traders to Action at Human Genome Sciences

 Today’s tickers: HGSI, MDRX, JPM, ESV, FLR & SD

HGSI - Human Genome Sciences, Inc. – Shares in biotechnology company Human Genome Sciences are down 3.95% this afternoon at $25.23 as of 3:15 pm, but one options trader populating the December contract today is positioning for the stock to rebound ahead of a key FDA decision on its lupus drug treatment, Benlysta. A preliminary FDA review is set for release in one week, while an advisory panel with outside experts is scheduled to provide their input before the FDA provides a final ruling by December 9, 2010. The optimistic options player is well positioned to benefit from a strong rally in the biotech firm’s shares should approval of the lupus treatment become a reality. The trader purchased 5,000 calls at the December $26 strike for a premium of $4.30 each, and sold the same number of calls at the higher December $32 strike at a premium of $1.36 apiece. Net premium paid for the spread amounts to $2.94 per contract. Thus, the investor makes money if Human Genome’s shares reverse course and rally 14.7% over the current price of $25.23 to surpass the effective breakeven point to the upside at $28.94 by expiration day. The call-spreader stands ready to amass maximum potential profits of $3.06 per contract if shares jump 26.8% to trade above $32.00 by December expiration. Options implied volatility on the biotechnology company is up 12.1% at 141.59% as of 3:30 pm, and will likely continue to ascend ahead of the FDA’s critical ruling.

MDRX - Allscripts-Misys Healthcare Solutions, Inc. – Call options on the provider of clinical software, services, information and connectivity solutions to physicians and other healthcare providers are in high demand today ahead of the firm’s third-quarter earnings report, which is scheduled for release after the market closes on Monday. Shares in Allscripts are currently up 1.3% at $19.44 as of 2:15 pm. Plain-vanilla call buyers were the first to arrive on the scene, but the majority of the options volume…
continue reading


Tags: , , , , ,




 
 
 

Phil's Favorites

What's behind the current wave of 'corporate activism'?

 

What's behind the current wave of 'corporate activism'?

Steffen Böhm, University of Exeter; Annika Skoglund, Uppsala University, and Dan Eatherley, University of Exeter

Recent years have witnessed the emergence of what appears to be a new breed of business person: the corporate activist. Hardly a week goes past without the head of some blue chip or other publicly agitating for a better world, be they ...



more from Ilene

Kimble Charting Solutions

Connect Series Webinar September 2018

Courtesy of Chris Kimble.

We cover dominating patterns in major global Indices, sectors, commodities and the metals markets.  We produce chart pattern analysis and empower people to improve entry and exit points.

To become a member of Kimble Charting Solutions, click here.

...

more from Kimble C.S.

ValueWalk

Global Return August 2018 Commentary: Thinking Differently

By Jacob Wolinsky. Originally published at ValueWalk.

Global Return Asset Management commentary for the month ended August 31, 2018; discussing Yahoo’s business model.

Dear Friends,

For the month of August, we generated a net return of 2.09%.1 We ended the month with 18% of assets in cash and had a net market exposure of 29%.

Q2 hedge fund letters, conference, scoops etc

Below is a new section we’re calling...

Think Differently

The purpose of this section is to...



more from ValueWalk

Zero Hedge

Investors Are Most Bearish Global Growth Since 2011 As They Go "All-In" US Decoupling

Courtesy of ZeroHedge. View original post here.

Even as the 244 respondents to the latest BofA Fund Manager Survey (who manage $724BN in AUM) plowed into US equities, as their September allocation to US stocks rose again, up 2% to 21%, the highest since Jan '15, making the US the most favored equity region globally for the second month running, amid bets the record divergence between the US and the rest of the world will continue for the indefinite future (or simply hoping upward momentum persists)...

...



more from Tyler

Insider Scoop

BankUnited Downgraded By Morgan Stanley On Headwinds Facing Mid-Cap Banks

Courtesy of Benzinga.

Related BKU Benzinga's Top Upgrades, Downgrades For September 18, 2018 BankUnited's Earnings Outlook

Mid-c...



http://www.insidercow.com/ more from Insider

Members' Corner

Nike, Colin Kaepernick and the pitfalls of 'woke' corporate branding

 

Adding this article to Members Corner, in case anyone wants to share opinions on Nike and Kaep, or on divisiveness in general. (Read the article I mentioned in the comments section, "A Warning From Europe: The Worst Is Yet to Come".) ~ Ilene

Nike, Colin Kaepernick and the pitfalls of 'woke' corporate branding

Courtesy of Simon Chadwick, University of Salford and Sarah Zipp, University of Stirling

Nike r...



more from Our Members

Biotech

Gene-editing technique CRISPR identifies dangerous breast cancer mutations

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

 

Gene-editing technique CRISPR identifies dangerous breast cancer mutations

Breast cancer type 1 (BRCA1) is a human tumor suppressor gene, found in all humans. Its protein, also called by the synonym BRCA1, is responsible for repairing DNA. ibreakstock/Shutterstock.com

By Jay Shendure, University of Washington; Greg Findlay, ...



more from Biotech

Chart School

Gold stocks, Elliot Wave and Volume

Courtesy of Read the Ticker.

Whom ever paints the chart with Elliot wave always has to try and sideline their bias. Elliot wave can work when it applied correctly and the chart is friendly to receive its application.

More from RTT Tv





Click for popup. Clear your browser cache if image is not showing.








Fundamentals are important, and so is market timing, here at readtheticker.com we believe a combination of ...

more from Chart School

Digital Currencies

A history of Bitcoin - told through the five different groups who bought it

 

A history of Bitcoin – told through the five different groups who bought it

GeniusKp/Shutterstock.com

Courtesy of Dave Elder-Vass, Loughborough University

The recent fluctuations in Bitcoin’s value are just the latest in a series of spectacular peaks and troughs since it was created in 2009. (Though its price has been falling recently, it remains five times higher than last April, before the l...



more from Bitcoin

Mapping The Market

Mistakes were Made. (And, Yes, by Me.)

Via Jean-Luc:

Famed investor reflecting on his mistakes:

Mistakes were Made. (And, Yes, by Me.)

One that stands out for me:

Instead of focusing on how value factors in general did in identifying attractive stocks, I rushed to proclaim price-to-sales the winner. That was, until it wasn’t. I guess there’s a reason for the proclamation “The king is dead, long live the king” when a monarchy changes hands. As we continued to update the book, price-to-sales was no longer the “best” single value factor, replaced by others, depending upon the time frames examined. I had also become a lot more sophisticated in my analysis—thanks to criticism of my earlier work—and realized that everything, including factors, moves in and out of favor, depending upon the market environment. I also realized...



more from M.T.M.

OpTrader

Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions

All About Trends

Mid-Day Update

Reminder: Harlan is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>